Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Oral Zn-Telomir Monotherapy in Patients With Advanced or Metastatic Triple-Negative Breast Cancer (TNBC)

Telomir Pharmaceuticals, Inc. · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
metastaticbreastcancertriple
triple-negative breast cancer (tnbc), advanced triple-negative breast cancer, metastatic triple-negative breast cancer, triple-negative breast cancer, zn-telomir, tnbc, metastatic breast cancer, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 844744
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.